Skip to main content
  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Cancer Therapeutics
Molecular Cancer Therapeutics
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

More articles from Research Articles: Therapeutics, Targets, and Development

  • Inhibition of Akt inhibits growth of glioblastoma and glioblastoma stem-like cells
    Gary L. Gallia, Betty M. Tyler, Christine L. Hann, I-Mei Siu, Vincent L. Giranda, Angelo L. Vescovi, Henry Brem, Gregory J. Riggins
    Molecular Cancer Therapeutics Feb 2009, 8 (2) 386-393; DOI: 10.1158/1535-7163.MCT-08-0680
  • Dasatinib-induced autophagy is enhanced in combination with temozolomide in glioma
    Vanessa Milano, Yuji Piao, Tiffany LaFortune, John de Groot
    Molecular Cancer Therapeutics Feb 2009, 8 (2) 394-406; DOI: 10.1158/1535-7163.MCT-08-0669
  • Effective sensitization of temozolomide by ABT-888 is lost with development of temozolomide resistance in glioblastoma xenograft lines
    Michelle J. Clarke, Evan A. Mulligan, Patrick T. Grogan, Ann C. Mladek, Brett L. Carlson, Mark A. Schroeder, Nicola J. Curtin, Zhenkun Lou, Paul A. Decker, Wenting Wu, E. Ruth Plummer, Jann N. Sarkaria
    Molecular Cancer Therapeutics Feb 2009, 8 (2) 407-414; DOI: 10.1158/1535-7163.MCT-08-0854
  • Effect of hypoxia on the expression of phosphoglycerate kinase and antitumor activity of troxacitabine and gemcitabine in non-small cell lung carcinoma
    Wing Lam, Scott Bussom, Yung-Chi Cheng
    Molecular Cancer Therapeutics Feb 2009, 8 (2) 415-423; DOI: 10.1158/1535-7163.MCT-08-0692
  • Dihydrofolate reductase amplification and sensitization to methotrexate of methotrexate-resistant colon cancer cells
    Cristina Morales, Maria J. García, Maria Ribas, Rosa Miró, Mar Muñoz, Carlos Caldas, Miguel A. Peinado
    Molecular Cancer Therapeutics Feb 2009, 8 (2) 424-432; DOI: 10.1158/1535-7163.MCT-08-0759
  • MAPK-independent impairment of T-cell responses by the multikinase inhibitor sorafenib
    Roland Houben, Heike Voigt, Christiane Noelke, Valeska Hofmeister, Juergen C. Becker, David Schrama
    Molecular Cancer Therapeutics Feb 2009, 8 (2) 433-440; DOI: 10.1158/1535-7163.MCT-08-1051
  • Interruption of RNA processing machinery by a small compound, 1-[(4-chlorophenyl)methyl]-1H-indole-3-carboxaldehyde (oncrasin-1)
    Wei Guo, Shuhong Wu, Li Wang, Rui-yu Wang, Xiaoli Wei, Jinsong Liu, Bingliang Fang
    Molecular Cancer Therapeutics Feb 2009, 8 (2) 441-448; DOI: 10.1158/1535-7163.MCT-08-0839
  • Trabectedin (ET-743) promotes differentiation in myxoid liposarcoma tumors
    Claudia Forni, Mario Minuzzo, Emanuela Virdis, Elena Tamborini, Matteo Simone, Michele Tavecchio, Eugenio Erba, Federica Grosso, Alessandro Gronchi, Pierre Aman, Paolo Casali, Maurizio D'Incalci, Silvana Pilotti, Roberto Mantovani
    Molecular Cancer Therapeutics Feb 2009, 8 (2) 449-457; DOI: 10.1158/1535-7163.MCT-08-0848
  • Notch1 mediates growth suppression of papillary and follicular thyroid cancer cells by histone deacetylase inhibitors
    Xueming Xiao, Li Ning, Herbert Chen
    Molecular Cancer Therapeutics Feb 2009, 8 (2) 350-356; DOI: 10.1158/1535-7163.MCT-08-0585
  • WIF1, a Wnt pathway inhibitor, regulates SKP2 and c-myc expression leading to G1 arrest and growth inhibition of human invasive urinary bladder cancer cells
    Yaxiong Tang, Anne R. Simoneau, Wu-xiang Liao, Guo Yi, Christopher Hope, Feng Liu, Shunqiang Li, Jun Xie, Randall F. Holcombe, Frances A. Jurnak, Dan Mercola, Bang H. Hoang, Xiaolin Zi
    Molecular Cancer Therapeutics Feb 2009, 8 (2) 458-468; DOI: 10.1158/1535-7163.MCT-08-0885

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 75
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About MCT

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Molecular Cancer Therapeutics
eISSN: 1538-8514
ISSN: 1535-7163

Advertisement